Highlights Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe Other stock markets 08:33:17 16/04/2026 BST			5-day change	1st Jan Change
116.20 ^GBX	0.00%		+11.00%	-9.66%

04-09	WINNERS & LOSERS: ME Group rises on Asda deal; BP tracks oil higher	AN
03-30	WINNERS & LOSERS: Miners climb; Close Brothers down before FCA verdict	AN

Highlights

03-17	Oxford Nanopore Technologies And A.D.A.M. Innovations Announce International Collaboration To Accelerate Advanced Genomic Medicine In Japan	CI
03-02	Oxford Nanopore Technologies plc Provides Earnings Guidance for the Year 2026	CI
03-02	Oxford Nanopore shares fall as revenue grows in 2025	AN
03-02	Oxford Nanopore Technologies plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-02	UK's Oxford Nanopore shares fall on medium-term revenue growth forecast cut	RE
03-02	Oxford Nanopore Technologies' FY25 Loss Shrinks; Revenue Rises	MT
03-02	Earnings Flash (ONT.L) Oxford Nanopore Technologies plc Reports FY25 Revenue GBP223.9M	MT
02-27	EARNINGS AND TRADING: B&M completes Jersey switch; Vox Valor in profit	AN
02-27	Oxford Nanopore Technologies says trial set for 2027 to adjudicate MGI Australia's defenses	RE
02-03	UK's FTSE 100 in the Red; Britain Pursues Stronger Ties with Switzerland, Japan	MT
02-03	UK, Japan Ink Life Sciences, Quantum, Connectivity Partnership Deals	MT
01-12	Oxford Nanopore says full year revenue will be slightly ahead of hopes	AN
01-12	Abivax, BESI and Exosens Surge, While SoftwareOne and Capgemini Struggle
01-12	British Land CEO to leave; Heathrow posts record year	AN
01-12	Oxford Nanopore Technologies plc Provides Earnings Guidance for the Full Year 2025	CI
01-12	Oxford Nanopore Expects FY25 Revenue Growth Slightly Ahead of Guidance	MT
01-12	Oxford Nanopore Technologies expects full year revenue growth slightly ahead of guidance	RE
12-19	Wasatch BioLabs Announces Co-Marketing Agreement with Agilent Technologies to Advance Native-Read Targeted Sequencing	CI
12-08	FTSE 100 called lower as Unilever spins off Magnum	AN
11-07	Oxford Nanopore Technologies Sees FY25 Revenue Growth at Top End of Guidance Range	MT
11-07	Oxford Nanopore shares up as expects annual growth at top end of range	AN
11-07	Oxford Nanopore Technologies expects 2025 revenue growth at top end of guidance	RE
11-07	Oxford Nanopore Technologies plc Reaffirms Earning Guidance for the Full Year 2025	CI
11-05	Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis	CI
11-05	Novogene Expands UK Offerings with Launch of ONT-Based Whole Plasmid Sequencing Service	CI